Not at all. Iv'e been in and around here for awhile, followed it pretty closely. They are trying to rebuild value on Travelan technology after the NASH/ASH/C-diff projects went nowhere. Those were big ticket items.
There is nothing to replace those on the agenda. If Travelan gets FDA approval(which I expect) then those projects may re-emerge and could be a big driver. The military involvement provides opportunities to sell on the news.
IMC Price at posting:
36.0¢ Sentiment: None Disclosure: Held
